Eli Lilly Survey: 90% Of Patients In Japan Feel Financial Burden Of Insulin, Want Cheaper Option
This article was originally published in PharmAsia News
Executive Summary
Three out of four Japanese receiving insulin are frustrated with the high financial costs of treatment, while more than 90% say they would change to a cheaper formulation with the same effect if a doctor recommended, according to a survey by Eli Lilly Japan.